Karyopharm Therapeutics Inc. buy BiotechBee
Start price
20.07.23
/
60%
€1.38
Target price
20.07.24
€3.00
Performance (%)
-41.97%
End price
10.07.24
€0.80
Summary
This prediction ended on 10.07.24 with a price of €0.80. Massive losses of -41.97% were the result for the BUY prediction by BiotechBee. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Karyopharm Therapeutics Inc. | -1.185% | -1.185% | -42.349% |
iShares Core DAX® | 1.280% | 1.320% | 13.605% |
iShares Nasdaq 100 | -2.457% | -5.192% | 25.941% |
iShares Nikkei 225® | -2.006% | -1.389% | 8.973% |
iShares S&P 500 | -0.662% | -1.884% | 23.684% |
According to BiotechBee what are the pros and cons of Karyopharm Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Buy mit Kursziel 3,0
In the thread Trading Karyopharm Therapeutics Inc.
Buy beendet